Skip to content
10-Q

Quarterly Report

REATA PHARMACEUTICALS INC

0000950170-23-039225

← back to feed
Filed
Aug 8, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2023 · Jun 30, 2023 41.51M sh
Shares Diluted Q2 2023 · Jun 30, 2023 40.76M sh
Shares Diluted Q2 2023 · Jun 30, 2022 36.47M sh
Shares Diluted Q2 2023 · Jun 30, 2022 36.44M sh
Capex Q2 2023 · Jun 30, 2023 $415K
Capex Q2 2023 · Jun 30, 2022 $2.56M
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$151.38M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$107.31M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $48.84M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $42.31M
Stockholders Equity Q2 2023 · Jun 30, 2023 $87.29M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$130.67M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$65.7M
Stockholders Equity Q2 2023 · Jun 30, 2022 $68.64M
Stockholders Equity Q2 2023 · Mar 31, 2022 $127.79M
Stockholders Equity Q2 2023 · Dec 31, 2021 $185.99M
Current Liabilities Q2 2023 · Jun 30, 2023 $125.09M
Current Liabilities Q2 2023 · Dec 31, 2022 $58.96M
Current Assets Q2 2023 · Jun 30, 2023 $401.85M
Current Assets Q2 2023 · Dec 31, 2022 $397.77M
Total Assets Q2 2023 · Jun 30, 2023 $502.59M
Total Assets Q2 2023 · Dec 31, 2022 $514.49M
Eps Diluted Q2 2023 · Jun 30, 2023 $4.65
Eps Diluted Q2 2023 · Jun 30, 2023 $1.89
Eps Diluted Q2 2023 · Jun 30, 2022 −$2.02
Eps Diluted Q2 2023 · Jun 30, 2022 −$4.04
Eps Basic Q2 2023 · Jun 30, 2023 $5.12
Eps Basic Q2 2023 · Jun 30, 2023 $2.06
Eps Basic Q2 2023 · Jun 30, 2022 −$2.02
Eps Basic Q2 2023 · Jun 30, 2022 −$4.04
Sga Expense Q2 2023 · Jun 30, 2023 $45.69M
Sga Expense Q2 2023 · Jun 30, 2023 $100.58M
Sga Expense Q2 2023 · Jun 30, 2022 $25.14M
Sga Expense Q2 2023 · Jun 30, 2022 $49.98M
Rd Expense Q2 2023 · Jun 30, 2023 $57.12M
Rd Expense Q2 2023 · Jun 30, 2023 $112.6M
Rd Expense Q2 2023 · Jun 30, 2022 $39.33M
Rd Expense Q2 2023 · Jun 30, 2022 $79.14M
Net Income Q2 2023 · Jun 30, 2023 $193M
Net Income Q2 2023 · Jun 30, 2023 $76.88M
Net Income Q2 2023 · Jun 30, 2022 −$73.56M
Net Income Q2 2023 · Jun 30, 2022 −$147.4M
Revenue Q2 2023 · Jun 30, 2023 $22.75M
Revenue Q2 2023 · Jun 30, 2023 $22.94M
Revenue Q2 2023 · Jun 30, 2022 $762K
Revenue Q2 2023 · Jun 30, 2022 $1.68M